[go: up one dir, main page]

GB0117755D0 - Immunity generation - Google Patents

Immunity generation

Info

Publication number
GB0117755D0
GB0117755D0 GBGB0117755.9A GB0117755A GB0117755D0 GB 0117755 D0 GB0117755 D0 GB 0117755D0 GB 0117755 A GB0117755 A GB 0117755A GB 0117755 D0 GB0117755 D0 GB 0117755D0
Authority
GB
United Kingdom
Prior art keywords
peptide
immunity generation
immunity
bacterial peptide
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0117755.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LEONARD CHRISTOPHER J
Original Assignee
LEONARD CHRISTOPHER J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEONARD CHRISTOPHER J filed Critical LEONARD CHRISTOPHER J
Priority to GBGB0117755.9A priority Critical patent/GB0117755D0/en
Publication of GB0117755D0 publication Critical patent/GB0117755D0/en
Priority to GB0217035A priority patent/GB2379875A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for the manufacture of a medicament for immunity generation includes providing an anti-bacterial peptide, and causing the anti-bacterial peptide to react with a bacterium, virus, fungus, parasite or mycobacterium to produce a reaction product which can be delivered as an antigen complex via the chemotactic T-cell pathway to promote an adaptive immune system. The antibacterial peptide(s) are preferably sourced from insect tissues and/or larval forms.
GBGB0117755.9A 2001-07-23 2001-07-23 Immunity generation Ceased GB0117755D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0117755.9A GB0117755D0 (en) 2001-07-23 2001-07-23 Immunity generation
GB0217035A GB2379875A (en) 2001-07-23 2002-07-23 Immunity generation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0117755.9A GB0117755D0 (en) 2001-07-23 2001-07-23 Immunity generation

Publications (1)

Publication Number Publication Date
GB0117755D0 true GB0117755D0 (en) 2001-09-12

Family

ID=9918901

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0117755.9A Ceased GB0117755D0 (en) 2001-07-23 2001-07-23 Immunity generation
GB0217035A Withdrawn GB2379875A (en) 2001-07-23 2002-07-23 Immunity generation

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0217035A Withdrawn GB2379875A (en) 2001-07-23 2002-07-23 Immunity generation

Country Status (1)

Country Link
GB (2) GB0117755D0 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4111782A1 (en) * 1991-04-11 1992-10-15 Gerhard Bayer Strengthening the immune system with propolis resin - dissolved in high strength ethanol@ to protect against bacterial and esp. viral infections
DE19543513A1 (en) * 1995-11-22 1997-06-12 Andreas Clemens Agent for treating human immuno-deficiency virus infection
ATE339443T1 (en) * 1998-12-02 2006-10-15 Entopharm Co Ltd IMMUNOMODULATORY AGENTS FROM CALLIPHORA VICINA LARVAE, THEIR PREPARATION AND USE
GB9913267D0 (en) * 1999-06-09 1999-08-04 Leonard Christopher J Immunity generation

Also Published As

Publication number Publication date
GB2379875A (en) 2003-03-26
GB0217035D0 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
MY125202A (en) Vaccine
AU2003270163A1 (en) Methods for producing an anti-microbial plastic product
AU2002355677A1 (en) Antigenic polypeptides
MY165643A (en) 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1311522A4 (en) New immunoeffector compounds
EP1728863A3 (en) C-class oligonucleotide analogs with enhanced immunostimulatory potency
AU2119200A (en) Medicament
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
AU2002358667A1 (en) Scented polymer capsules and the production thereof
WO2005046579A3 (en) Defined dose therapeutic phage
BE2021C506I2 (en)
TW200510449A (en) Acylated nonadepsipeptides
WO2023004415A3 (en) Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments
YU8804A (en) Single dose azithromycin
IL165989A (en) Process for producing a virus-inactivated thrombin preparation
IL163304A (en) Immunoeffector compounds
WO2003046007A3 (en) Treatment of micro-organism infection
MX2012004622A (en) Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof.
GB0117755D0 (en) Immunity generation
BR0212504A (en) Materials and methods for autologous t-cell vaccine
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
MXPA03008906A (en) Biosynthetic genes for butenyl-spinosyn insecticide production.
PL1615656T3 (en) Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
WO2001077365A3 (en) Antimicrobial methods and materials

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)